SHANNON JOHN PATRICK JR (See Remarks) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/2/2026ACC: 0001553595-26-000004
Officer· See Remarks
Since Oct 2021
+777.57K
Net shares
Net buyer
$2.51M
Total sold
0
Open market trades
0B · 0S
5
Total transactions
1.12M acquired · 340.50K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+478.44K
Price / share
—
Trade value
—
% of position
17.1%
1/30/2026
2.80M→3.28M
Common Stock
Direct
Shares
−118.13K
Price / share
$7.36
Trade value
$869.47K
% of position
3.6%
1/31/2026
3.28M→3.16M
Common Stock
Direct
Shares
−111.62K
Price / share
$7.36
Trade value
$821.53K
% of position
3.5%
1/31/2026
3.16M→3.05M
Common Stock
Direct
Shares
−110.75K
Price / share
$7.36
Trade value
$815.12K
% of position
3.6%
1/31/2026
3.05M→2.94M
Total
Net shares
+137.93K
Net value
-$2.51M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2026 | A · Award | +478.44K | — | — | 17.1% | 2.80M | 3.28M |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −118.13K | $7.36 | $869.47K | 3.6% | 3.28M | 3.16M |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −111.62K | $7.36 | $821.53K | 3.5% | 3.16M | 3.05M |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −110.75K | $7.36 | $815.12K | 3.6% | 3.05M | 2.94M |
| Total | +137.93K | -$2.51M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
639.64K shares
Shares
+639.64K
Strike price
7.36
Held after
639.64K
Exercisable
—
1/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock639.64K shares | 1/30/2026 | A · Award | +639.64K | 7.36 | — | 639.64K |